Hester Biosciences Limited — Others, 02-08-2025: Copy of Newspaper Publication

Hester Biosciences has published its consolidated unaudited financial results for the quarter ended June 30, 2025. The company reported a consolidated total income of INR 86.42 Cr and a net profit after tax of INR 17.30 Cr for the quarter. Consolidated earnings per share stood at INR 20.33. Additionally, standalone results show a total income of INR 64.44 Cr and a net profit after tax of INR 7.84 Cr, with standalone EPS at INR 9.21. This update provides investors with key insights into the company's recent operational performance.